John Bell

The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK.

The Jenner Institute Laboratories engages in the development of vaccine against major diseases. The company was founded in November 2005 and is headquartered in Oxford, the United Kingdom.

The Oxford Health Alliance is a British charitable company that focuses on preventing chronic diseases. The non-profit company is based in Greater London, UK.

Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom.

Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom.

Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom.

Biospring Management Partners LP (Biospring Partners) is a venture capital firm founded in 2020 by Michelle Dipp and Jennifer Lumba. The firm is headquartered in New York.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.